Monogram Technologies Inc., an AI-driven robotics company specializing in orthopedic surgery, announced the mandatory conversion of its 8.00% Series D Convertible Cumulative Preferred Stock. This decision comes after the company's common stock maintained a closing price of at least $2.8125 per share for ten consecutive trading days, triggering the conversion as per the terms outlined in the Certificate of Designation. The conversion will take effect on July 14, 2025, impacting all outstanding shares issued during the company's October 1, 2024 offering. This strategic move is part of Monogram's ongoing efforts to streamline its capital structure and enhance shareholder value.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.